Please login to the form below

Not currently logged in
Email:
Password:

New head for Deallus Consulting

Claudio D’Ambrosio is to take over as CEO at life sciences consultancy

Dr-Claudio-D Ambrosio Deallus-ConsultingThe life sciences consultancy Deallus Consulting has named Claudio D'Ambrosio as its new CEO, effective September 1, 2014.

D'Ambrosio joined Deallus in 2008 to lead its oncology practice. Since 2011, has served as head of North American operations for the consultancy.

He will succeed Richard Withers, the founder and current CEO, who will remain on the board of Deallus Holdings.

“We are extremely excited about Claudio's appointment. He brings a tremendous energy and a fresh approach to how we can achieve our vision and strategic imperatives and I have no doubt he is the right person to build on the success we have achieved under Richard's leadership,” said Hunt.

D'Ambrosio added that he was delighted to have the opportunity to lead Deallus through its next phase of growth.

“This is a really exciting time for the company as we continue on our growth trajectory and strive to cement our position as leaders in life science consulting,” he said.

“The core values that are embedded in the business and the immensely talented team that have grown and shaped the organisation give me a great sense of confidence about the future.”

Deallus was founded in the UK in 2004. Today the consultancy has close to 100 employees and offices in London, New York, New Jersey, Los Angeles and Singapore.

22nd July 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics